[1] |
LI Shunle, LI Rong, TIAN Yaya, RAN Xiaoli, ZHAO Yanpei, XU Meng.
Association of serum KLF5 and actinin-4 levels with prognosis of TACE treatment for hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2024, 44(9): 1284-1289.
|
[2] |
LU Huiying, WANG Jianguo.
Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2
[J]. Basic & Clinical Medicine, 2024, 44(2): 185-191.
|
[3] |
Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing.
Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2023, 43(9): 1417-1422.
|
[4] |
LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan.
Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice
[J]. Basic & Clinical Medicine, 2023, 43(8): 1241-1246.
|
[5] |
ZOU Jin, HE Xianglei, ZHANG Xin, CHEN Riping, ZHANG Yu, HU Shuaiyue, YING Shibo.
Expression of chemical modification enzymes PADs and PRMTs targeting protein arginine residues in human hepatocellular carcinoma cell lines
[J]. Basic & Clinical Medicine, 2023, 43(6): 898-903.
|
[6] |
JI Mengdie, YUAN Zan, BIAN Xiaocui, YANG Yurong, GUO Xin, WANG Qi, CHEN Yang.
Analysis of genomic copy number variations in human hepatocellular carcinoma cell lines HepG2 and Huh7
[J]. Basic & Clinical Medicine, 2023, 43(6): 960-966.
|
[7] |
LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao.
The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H
[J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.
|
[8] |
CHA Na, HAO Dandan, LI Tianzhu.
Research progress of microRNAs suppressing tumorigenesis through Hippo signaling
[J]. Basic & Clinical Medicine, 2023, 43(12): 1871-1875.
|
[9] |
HUANG Yisheng, YE Qiwen, WANG Jingfeng.
miR-203a-3p inhibits proliferation of human hepatocellular carcinoma cell lines
[J]. Basic & Clinical Medicine, 2023, 43(1): 87-94.
|
[10] |
ZHAO Yu-shan, JI Meng-die, DONG Yu-cheng, GUO Xin, SONG Bo-yuan, CHEN Yang.
Epigenetic regulation mechanism of EZH2 gene in hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(6): 864-870.
|
[11] |
CHEN Qian, LIU Xian, CUI Nan, ZHAI Yang.
Knockout of EZH2 inhibits migration and invasion of human cervical cancer cell lines
[J]. Basic & Clinical Medicine, 2022, 42(3): 395-400.
|
[12] |
HUANG Rong, ZHANG Jian, CHE Xu.
Effect of SLC4A10 expression on prognosis of patient with hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(3): 461-466.
|
[13] |
MI Yue, JIANG Qi-wei, SHEN Yan-jie, ZHANG De-yu, YE Qi-nong.
Construction and functional verification of AP-2 gene family eukaryotic expression vector
[J]. Basic & Clinical Medicine, 2022, 42(12): 1829-1834.
|
[14] |
WANG Yu-min, CHEN Ji-chao, WANG Hong-quan, WANG Jin-hua, TANG Bo.
Research progress of microRNAs as remodelers of lipid metabolic reprogramming in hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(12): 1930-1934.
|
[15] |
WAN Xue-qiong, CHEN Jia, HE Chao, YE Xing-ming.
Zerumbone inhibits the proliferation, migration and invasion of human non-small cell lung cancer cell line A549 through up-regulating FBXW7 expression
[J]. Basic & Clinical Medicine, 2021, 41(8): 1163-1168.
|